AETHLON MEDICAL INCAEMDEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
Aethlon Medical Inc. is a clinical-stage medical technology firm that develops targeted therapeutic devices to address life-threatening health conditions. Its lead product, the Hemopurifier, is designed to remove harmful viruses, cancer-derived exosomes, and other pathogens from the bloodstream. The company primarily operates in the infectious disease and oncology healthcare segments, with main market presence in North America.
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-17 | BROENNIMAN EDWARD G | Director | Grant | 21.8K | $2.29 | $50.0K |
| 2026-04-17 | Nicolas Gikakis | Director | Grant | 21.8K | $2.29 | $50.0K |
| 2026-04-17 | Chetan Shah | Director | Grant | 21.8K | $2.29 | $50.0K |
| 2026-04-17 | Angela Rossetti | Director | Grant | 21.8K | $2.29 | $50.0K |
1–4 of 4